CCM
ATRC icon

Consonance Capital Management’s AtriCure ATRC Stock Holding History

Consonance Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,849,185
Closed -$69.1M – 21
2017
Q2 		$69.1M Sell
2,849,185
-37,169
-1% -$790K 8.14% 6
2017
Q1 		$55.3M Buy
2,886,354
+220,000
+8% +$3.85M 5.79% 9
2016
Q4 		$52.2M Buy
2,666,354
+2,434,428
+1,050% +$44.1M 5.73% 7
2016
Q3 		$3.67M Buy
+231,926
New +$3.57M 0.35% 20

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HEC
Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Consonance Capital Management's ATRC Position: Q3 2017 in Review

Consonance Capital Management sold out of AtriCure (ATRC) in Q3 2017, closing a stake of 2,849,185 shares — an estimated $69.1M sold.

Consonance Capital Management first reported a position in ATRC in Q3 2016 and held it in 4 quarters. The position peaked at $69.1M in Q2 2017. 114 funds tracked by Wall St. Rank hold ATRC as of Q3 2017.

  • Consonance Capital Management reported no remaining AtriCure position as of Q3 2017 after selling out during the quarter.
  • Consonance Capital Management sold 2,849,185 AtriCure shares in Q3 2017, an estimated $69.1M.
  • Consonance Capital Management first reported a position in AtriCure in Q3 2016 and held it in 4 quarters.
  • Consonance Capital Management's AtriCure position peaked at $69.1M in Q2 2017.
  • 114 funds tracked by Wall St. Rank held AtriCure as of Q3 2017.

Based on Consonance Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.